127.16
3.76 (3.05%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | BioNTech SE | Bullish | Bullish |
Stockmoo Score
|
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Flossbach Von Storch Ag | 30 Jun 2024 | 4,379,483 |
| Harding Loevner Lp | 30 Jun 2024 | 2,926,761 |
| Quinn Opportunity Partners Llc | 30 Jun 2024 | 683,287 |
| Altrinsic Global Advisors Llc | 30 Jun 2024 | 676,219 |
| Deerfield Management Company, L.P. (Series C) | 30 Jun 2024 | 594,000 |
| Candriam S.C.A. | 30 Jun 2024 | 578,998 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 150.00 (Jefferies, 17.96%) | Buy |
| 150.00 (B of A Securities, 17.96%) | Buy | |
| Median | 131.00 (3.02%) | |
| Low | 113.00 (HC Wainwright & Co., -11.14%) | Buy |
| Average | 133.80 (5.22%) | |
| Total | 3 Buy, 2 Hold | |
| Avg. Price @ Call | 123.81 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 18 Sep 2024 | 131.00 (3.02%) | Hold | 124.33 |
| Jefferies | 17 Sep 2024 | 150.00 (17.96%) | Buy | 124.33 |
| 13 Sep 2024 | 96.00 (-24.50%) | Hold | 123.40 | |
| B of A Securities | 16 Sep 2024 | 150.00 (17.96%) | Buy | 123.47 |
| HC Wainwright & Co. | 16 Sep 2024 | 113.00 (-11.14%) | Buy | 123.47 |
| 27 Aug 2024 | 113.00 (-11.14%) | Buy | 87.11 | |
| JP Morgan | 16 Sep 2024 | 125.00 (-1.70%) | Hold | 123.47 |
| 15 Aug 2024 | 91.00 (-28.44%) | Sell | 87.25 |
No data within this time range.
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 02 Jun 2022 | - | 17 Jun 2022 | 2.111 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2022 | 2.11 | 1 | 1.41 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |